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Gangliosides, a class of biologically active cell surface molecules, are expressed in particularly high concentrations on the plasma membranes of tumor cells, from which they are actively shed (1-3) into the cellular microenvironment (4-7). Their chemical structure consists of a carbohydrate portion (one or more sialic acids linked to an oligosaccharide) attached to a lipid composed of a long-chain base and a fatty acid (ceramide). The known properties of gangliosides include antigenic specificity (8) , immunosuppressive activity (9) , and roles in cell recognition (10) , adhesion (11) , and signal transduction (12) . The importance of the ceramide portion, which anchors the ganglioside molecule in the cell membrane, is suggested by recent studies showing that some glycosphingolipid metabolic products, such as lysogangliosides (13) (14) (15) , sphingosine (15) (16) (17) , and ceramide (18) , may modulate intracellular signal transduction as second messen- gers.
Here we show that the molecular structure of the ceramide portion of naturally occurring gangliosides has a previously unrecognized functional importance. A simple difference in ceramide structure ofthe intact ganglioside-the length ofthe fatty acyl chain-dramatically influences ganglioside immunosuppressive activity. Gangliosides with shorter fatty acyl chains are far more potent in inhibiting the in vitro human lymphoproliferative response to a soluble antigen than are those containing longer fatty acyl chains. Importantly, these ganglioside species having shorter fatty acid chains (and thereby more potent immunosuppressive activity) are exactly the same species that are preferentially shed into the tumor microenvironment by tumor cells (19, 20) .
MATERIALS AND METHODS
Gangioside Purification. Total gangliosides were purified from normal human brain and from human and munne tumor cells by a sequence of steps including extraction of the cells with chloroform/methanol, 1:1 (vol/vol), partition of the total lipid extract in diisopropyl ether/1-butanol (21) , and Sephadex G-50 gel filtration of the ganglioside-containing aqueous phase.
HPLC. Individual gangliosides were separated and purified by HPLC methods ofGazzotti et al. (22, 23 (24) .
Gangliosde Quantification, Strucural Characterlzatlon, and Radbeling. Gangliosides were quantified by resorcinol assay (25) and analyzed by high performance thin-layer chromatography (HPTLC). The developing solvent system was chloroform/methanol/0.2% CaCl2'2H20, 60:40:9 (vol/ vol), and the gangliosides were visualized by resorcinol staining. Ganglioside structures were confirmed by negativeion fast atom bombardment mass spectrometry and collisionally activated dissociation tandem mass spectrometry. For binding studies (9) , the individual molecular species of GD2 ganglioside were radiolabeled with tritiated borohydride (26) and purified.
Lymphocyte Proliferation Assay. An assay of antigeninduced human lymphoproliferation has been used to measure the immunosuppressive effects of purified gangliosides (9) . Normal human peripheral blood mononuclear leukocytes (PBMCs) were isolated by Ficoll/Hypaque density gradient centrifugation (27) from whole blood collected in preservative-free heparin (50 units/ml). The cells were washed three times and resuspended in complete HB104 medium. Autologous human plasma was added to a final concentration of 0.5%. Normal human PBMCs were cultured in 96-well (A/2) tissue culture clusters (Costar 36%).
Gangliosides purified by HPLC were suspended in medium by brief sonication before addition to the cell cultures.
Ganglioside solution was added at 10 gl per well, followed by addition ofthe PBMCs (25 Al, 2 x 106 cells per ml ofcomplete medium). After a 3-h preincubation at 370C, 10 /4 of the previously determined optimal concentration of the stimulant of lymphoproliferation, tetanus toxoid [3. 5 Lf (limes flocculating) doses/ml, Massachusetts Department of Health, Boston] was added. Basal medium (10 /4 per well) alone was added to unstimulated control cultures. The complete cultures were incubated at 370C in 95% air/5% CO2 for 6 days (9). As has been documented under these conditions (9) 
RESULTS AND DISCUSSION
Relative Immunosuppressive Activity ofTumor-Derived and Normal Brain Gangliosides. Comparison of a series of highly purified normal human brain gangliosides showed that those with a terminal sialic acid linked to a compact neutral oligosaccharide had the highest immunosuppressive activity (9) . Because of a particular interest in tumor gangliosides, we also studied the analogous tumor-derived ganglioside molecules. We assumed that any specific ganglioside, whether isolated from a human tumor or from normal human brain, should have the same immunosuppressive activity. Surprisingly, we found that naturally occurring human and other vertebrate tumor gangliosides are frequently more immunosuppressive than are the corresponding normal human brain gangliosides. For example, GD2 isolated from a human neuroblastoma was significantly more active than GD2 from normal human brain tissue (Fig. 1) . Since the tumor-derived GD2 and the brain-derived GD2, which were characterized by HPTLC, mass spectrometry, and immunostaining with an anti-GD2 monoclonal antibody, had identical carbohydrate structures, the explanation for this difference was not intuitively obvious. The only possible difference between these two gangliosides on a molecular basis was in their ceramide structure. This led us to postulate that ceramide structure, a relatively unstudied portion of the ganglioside molecule, is critical in determining ganglioside biological activity.
Ceramide Structural Diversity of Human Neuroblastoma Gangliosides. To determine how ceramide structure affects immunosuppressive activity of gangliosides, we first isolated GD2 from LAN-5 human neuroblastoma cells (Fig. 2) . By using recently developed techniques (28), we isolated and purified GD2 to homogeneity with respect to both carbohydrate and ceramide structure. Although GD2 is generally considered a single molecular species, we found that actually carbohydrate structure, GD3 (e) and GD2 (U), isolated from human neuroblastoma tissue. An assay of antigen-induced human lymphoproliferation was used to measure the immunosuppressive effects of purified gangliosides (9) . The range of the proliferative response of multiple control cultures, not exposed to gangliosides, is shown. The data represent the mean of three experiments; the SEM was <10% of the mean. it is not: GD2 could be separated into four major and many minor peaks by reversed-phase HPLC, each peak representing a different molecular species (Fig. 3) . Structural characterization by mass spectrometry revealed that every one of these species has a different ceramide structure linked to the same carbohydrate structure of GD2. Within the ceramide, although the long-chain base structure was constant (sphingosine, d18:1), substantial differences occurred in the fatty acids that varied in the length of the fatty acyl chains from 16 Fig. 2 . This GD2 was further resolved into multiple individual ceramide species by reversed-phase HPLC (23) . Four major peaks were isolated, and their ceramide structures were determined by negative-ion fast atom bombardment mass spectrometry and collisionally activated dissociation tandem mass spectrometry (29) . All species are GD2 with the same carbohydrate structure and long-chain base (sphingosine, d18:1). They differed only in the fatty acid compositions, as shown in the figure. Their relative proportion, by HPLC estimation, was C16:0 (13%), C18:0 (12%), C22:0/C24:1 (41%), and C24:0 (14%). these individual ceramide subspecies isolated from GD2 had markedly different immunosuppressive activity (Fig. 4) . GD2 molecules containing fatty acids of 16 and 18 carbon atoms were >6 times more active than gangliosides with fatty acids of 22 and 24 carbon atoms. This very dramatic difference in effectiveness of immunosuppression can also be seen in the ID50. The ID50 value for GD2 with the shortest fatty acid (16 carbons) was 0.4 uM or 10-fold lower than that of the GD2 molecule with the longest fatty acid (24 carbons, >5.0 ,uM). These overall results define an inverse relationship between the degree of activity and the length of the fatty acyl chains in GD2 ceramide subspecies and suggest that ganglioside immunosuppressive activity is enhanced when the fatty acyl chain is among the naturally occurring shorter fatty acid species.
We considered the possibility that striking differences in immunosuppressive activity related to ganglioside ceramide structure could be due to differential binding of these molecules to PBMCs. We therefore quantified the binding of 5 Fig. 3 had the carbohydrate structure of GD2 and the same long-chain base (sphingosine, d18:1) and differed only in fatty acid structure. These molecules were tested for immunosuppressive activity as described in Fig. 1 . Activity of the individual species is shown. The fatty acids were C24:0 (v), C22:0/C24:1 (v), C18:0 (v), and C16:0 (-). Highly purified total GD2 (0), which is a mixture of the ceramide species, had intermediate activity. carbohydrate structure of the ganglioside molecules? Or, are these findings restricted to GD2? To answer this question, two other gangliosides, SPG and GalNAcGMlb were isolated from two other tumors, a human leukemia and a murine lymphoma, respectively. They were separated and characterized in the same way as were the GD2 gangliosides. Two major ceramide species of each ganglioside were identified, and again they differed only in the fatty acyl chain (length 16 and 24 carbons). When SPG and GaINAcGMlb were tested for immunosuppressive activity, in each case the ganglioside containing a short fatty acyl chain (16 carbons) was much more immunosuppressive than the same ganglioside containing a 24-carbon fatty acyl chain (Fig. 5) . Thus, independent of the origin of the gangliosides (human or mouse; neuroblastoma, lymphoma, or leukemia), greater immunosuppressive activity is associated with gangliosides containing shorter-chain fatty acids. The present work, therefore, clearly defines the important concept that the ceramide structure of the ganglioside molecule dramatically influences ganglioside immunosuppressive activity.
How do these findings relate to what is already known about ceramide? Ceramide (18, (30) (31) (32) and certain lipid molecules, either structurally or metabolically related to ceramide [e.g., sphingosine 1-phosphate (16, 17) and sphingolipid breakdown products such as lysogangliosides (13) (14) (15) ], may have important functional roles, such as in membrane signal transduction. Other synthetic lipid molecules, including D-threo-l-phenyl-2-decanoylamino-3-morpholino-1-propanol, an analogue of ceramide, block the synthesis of glycosphingolipids and affect cell growth, cell adhesion, and mitogen-stimulated lymphocyte proliferative responses (33) (34) (35) . Finally, ceramide, as a structural component of the intact glycosphingolipid molecule, affects ganglioside-monoclonal antibody binding affinity (36) . It also influences the relative antigenicity of glycolipids (37, 38) probably by affecting exposure of the carbohydrate epitope in the cell plasma membrane.
It is known that the ceramides from certain normal ganglioside molecules (e.g., bovine brain gangliosides) have no immunosuppressive activity when cleaved from the carbohydrate portion of the molecule (39) . To confirm whether this is true for ceramides found in tumor gangliosides, we assessed the immunosuppressive activity of ceramides containing C18 (Matreya, Inc) or C24/C18 (type III, Sigma) fatty acyl groups under the same conditions as intact gangliosides were studied. Neither of these ceramides was active (ID50> 30 ,uM). Thus, the immunosuppressive activity of tumorassociated gangliosides cannot be reproduced by the ceramide alone. One can conclude that while the immunosuppressive activity requires the intact ganglioside consisting of both carbohydrate and ceramide moieties, the molecular structure of the ceramide predicts degree of activity.
Gangliosides interfere with the cellular immune response by at least several mechanisms. These include reversible inhibition of adherent leukocyte antigen processing/presentation (40) , direct binding to cytokines such as interleukin 2 (41, 42) , and downregulation of CD4 expression (43) . Programmed cell death, or apoptosis, may also be influenced by gangliosides and related molecules. Most recently, C2-ceramide has been shown to cause apoptosis (44) and globotriaosylceramide may be a receptor for a signal molecule that induces apoptosis (45) , whereas ganglioside GM1 protects against tumor necrosis factor-induced apoptosis (46) . The lack oftoxicity ofgangliosides to PBMCs (4, 9, 47), reversible inhibition (40) , and the protective effects of GM1 (46) all argue against gangliosides acting by causing apoptosis. Clearly, however, the molecular mechanisms of immunosuppression by tumor gangliosides remain to be established.
The present findings provide another perspective on ganglioside function and ceramide structure. Tumor gangliosides clearly have a dynamic effect on the tumor cell microenvironment and are a critical factor in tumor formation and progression (48) . By the continuous (20) shedding of these biologically active cell surface molecules, the tumor cell creates a microenvironment containing a high concentration of tumor-derived gangliosides that may downregulate the host antitumor response by inhibiting the function of leukocytes that infiltrate tumors, thereby facilitating tumor progression. The accumulated evidence supports this hypothesis. In vitro, gangliosides inhibit several steps in the cellular immune response, such as antigen processing/presentation (40) , lymphocyte proliferation (4, 47, (49) (50) (51) , and cytotoxic effector function (52) (53) (54) . In vivo, tumor formation by otherwise poorly tumorigenic cells can be enhanced by the addition of gangliosides in experimental model systems (48, 55) . In humans, substantial shedding was chemically detected in the circulation of patients with neuroblastoma (6) and tumor progression is highly linked statistically to the circulating concentration of shed tumor gangliosides (56) . And gangliosides with short fatty acyl chains, which we identified to be highly immunosuppressive, are also those molecules that are selectively shed by tumors such as neuroblastoma (20) , leukemia and lymphoma (57, 58) , melanoma (7, 19) , and sarcoma (59) . The combined findings strongly suggest that the tumor cell is optimized to protect itself in vivo by selective shedding of certain highly active ganglioside species. Finally, since gangliosides inhibit antigen-induced proliferation of PBMCs without toxicity to unstimulated resting cells (9) , certain highly active ganglioside structures may, under other circumstances, paradoxically have therapeutic potential as immunosuppressive molecules.
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